Skip to content
Home/Companies/Pharma/DMX Pharma
DP

DMX Pharma

Pharma·Italy·Exited 2025·Held 3yr

DMX Pharma is a pharma company, headquartered in Italy.

Entry
2022
Hold
3yr
Exit
2025
Est. EV
–

Who owns DMX Pharma?

DMX Pharma was owned by Alto Partners SGR through Alto Capital IV (2017 vintage) from 2022 to 2025, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-19

Alto Partners SGR
Investor
Alto Partners SGR
Alto Capital IV · 2017 · Small-Mid Buyout

Key facts

HQItaly
SectorPharma
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2025

More from Alto Capital IV

Other portfolio companies in the same fund.

CEI (reinvestment)
Active
IndustrialsItaly· 2022
Diatech
Exited 2023
BiotechItaly· 2021
to
CEI
Exited 2022
IndustrialsItaly· 2020
to
Bia
Exited 2022
ConsumerItaly· 2019
to
OFI
Exited 2020
PharmaItaly· 2019
to
Olimpia Splendid
Exited 2025
IndustrialsItaly· 2019
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Crossject
Active
VATEL CAPITALFrance· 2025
Data refreshed weekly · Sourced from public filings